Therapy using brain stimulation for children with ADHD
Official title: ADHD PreSMA Response Inhibition Therapy
Run by Children's Hospital Medical Center, Cincinnati · NCT06325813 · Data updated 2026-11-12
This study is testing whether a special brain stimulation treatment can help children with ADHD improve their ability to control their impulses.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 17 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Status | Recruiting |
| Started | September 3, 2024 |
| Main results expected | May 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | January 27, 2026 |
| Trial ID | NCT06325813 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 12-17 with a diagnosis of ADHD who can temporarily discontinue stimulant medications.
✕Probably not a fit
Patients with significant medical conditions, implanted devices, or other psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of Transcranial Magnetic Stimulation (TMS) on children aged 12-17 diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Participants will undergo cognitive testing and brain MRI, followed by baseline measures of inhibitory control. They will receive two trains of Intermittent Theta Burst Stimulation (iTBS), with the first being randomized between active and sham stimulation. The study aims to assess changes in inhibitory control through behavioral tasks and EEG data collection before and after the intervention.
Why it matters
Potential benefit: If successful, this therapy could improve inhibitory control in children with ADHD, potentially leading to better management of their symptoms.
How similar studies have gone: Previous studies using TMS for ADHD have shown promising results, indicating that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ADHD diagnosis 2. Ages 12-17 years 3. Stimulant use is allowed but must be discontinued 24 hours prior to and during days of TMS visit Exclusion Criteria: 1. Medical conditions contraindicated or associated with altered TMS risk profile, including history of intracranial pathology, epilepsy or seizure disorders, traumatic brain injury, brain tumor, stroke, intellectual disability, cerebral palsy, neurodegenerative conditions, hearing impairment, metallic objects in the head or any other serious medical condition 2. Presence of any implanted medical devices (e.g., ports, shunts, stimulators, cochlear implants) 3. For biological females who are post-menarche, current pregnancy based on urine pregnancy test. 4. Baseline problem of hearing impairment or chronic tinnitus 5. Any clinically significant finding on brain MRI 6. History of DSM-5 conduct disorder, major depressive disorder, bipolar disorder, obsessive compulsive disorder, anxiety disorder, psychotic disorder 7. Non-stimulant medication(s) for ADHD (e.g., alpha2 adrenergic agonist, atomoxetine, tricyclics) 8. Neuroleptic/antipsychotic medication(s) 9. Inability to undergo MRI 10. Active suicidality, history of suicidality, or high risk for suicide as assessed by a study physician 11. Substance abuse or dependence within the past year, based on 1) separate screening process of asking parent/guardian and participant, and 2) positive urine drug screen. Exception will be made for positive urine drug screen due to prescribed ADHD medication
Where it's running
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting
Study contacts
- Principal investigator: Steve W Wu, M.D. — Children's Hospital Medical Center, Cincinnati
- Study coordinator: Karlee Migneault, B.A.
- Email: Karlee.Migneault@cchmc.org
- Phone: 513-803-5299
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Foquest in older adults with ADHD: daily methylphenidate for 65+
This study tests whether once-daily Foquest helps symptoms in adults 65 and older with ADHD.
-
Neuroplasticity-targeted supplements for ADHD in children
A 12-week randomized trial tests whether gut- and brain-targeted supplements can help reduce ADHD symptoms in children aged 6–12.
-
Therapy approaches for irritability in youths: active treatments vs nonactive psychoeducation
This study tests whether active psychotherapies for irritability in kids aged 8–16.5 years work better than nonactive, time-matched psychoeducation for children and their parents.
-
Playful physiotherapy to support children with ADHD or autism
This program will try a play-based physiotherapy approach to see if it improves emotional, behavioral, and social functioning in Estonian-speaking children aged 5–12 with ADHD or autism.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
-
Transcranial infrared light to the prefrontal cortex for adults with ADHD
This trial will try using transcranial infrared light on the prefrontal cortex to see if it improves attention, impulse control, and working memory in adults with ADHD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.